Summary
Switzerland recorded an export record in 2025: exports rose by 1.4 percent to 287.0 billion francs. After two weak years, imports increased by 4.5 percent to 232.7 billion francs – the second-highest value in history. The chemical and pharmaceutical industry is driving this development. The positive trade balance of 54.3 billion francs signals Swiss competitive strength in the global market.
Persons
- No specific persons mentioned
Topics
- Swiss foreign trade
- Exports and imports
- Chemical-pharmaceutical industry
- Trade balance
Clarus Lead
Switzerland set an export record in 2025: exports reached 287.0 billion francs. After two years of import declines, imports are also recovering (+4.5 percent). This development underscores the continued export strength of the Swiss economy, particularly in the chemical and pharmaceutical industry.
Clarus Own Performance (Mandatory)
Clarus Research: The export increase of 1.4 percent reaches a historic high; in parallel, imports at 232.7 billion francs mark the second-highest value since records began – a sign of economic stabilization following previous years' weakness.
Classification: The positive trade balance of 54.3 billion francs illustrates Swiss specialization advantage in high-value segments (chemicals, pharmaceuticals, precision). This compensates for structural disadvantages in raw materials and mass production.
Consequence: Decision-makers in export-oriented industries receive confirmation for investments in research and innovation; simultaneously, the import recovery signals rising demand for intermediate products and raw materials – an indicator of economic expansion.
Detailed Summary
Swiss foreign trade shows consistently positive signals in 2025. Exports grew moderately but reached a new record value of 287.0 billion francs. This 1.4 percent increase is substantially driven by the chemical and pharmaceutical industry, which traditionally represents Swiss export strength.
Particularly noteworthy is the recovery in imports. After two consecutive years of declines, imports in 2025 increased by 4.5 percent and reached 232.7 billion francs. This is the second-highest value in Swiss trade statistics – a signal of restored demand for intermediate products and raw materials.
The trade balance benefits from this asymmetry: with a surplus of 54.3 billion francs, Switzerland remains a net exporter. This structural strength is based on specialization in value-intensive sectors.
Key Statements
- Swiss exports reach a new record of 287.0 billion francs in 2025 (+1.4 percent).
- Imports recovered after two weak years by 4.5 percent to 232.7 billion francs (second-highest historical value).
- The trade balance shows a surplus of 54.3 billion francs.
- Chemical and pharmaceutical industry are the main drivers of export dynamics.
Stakeholders & Affected Parties
| Group | Impact |
|---|---|
| Chemical-Pharma Companies | Benefit from export record and global demand |
| Suppliers & Intermediate Product Manufacturers | Benefit from increased import demand |
| Employees in Export Industries | Job security through order volume |
| SMEs in Domestic Market | Utilize rising import demand for growth |
| Consumers | Potentially higher prices due to increased import costs |
Opportunities & Risks
| Opportunities | Risks |
|---|---|
| Strengthening export economy through record values | Dependence on few sectors (chemical-pharma) |
| Employment effects in export industries | Currency volatility could jeopardize price advantage |
| Restored import demand strengthens supply chains | Geopolitical tensions could block export markets |
| Solid trade balance stabilizes franc exchange rate | Raw material price increases raise import costs |
Action Relevance
For Exporters:
- Continue investments in capacity and innovation; record values show market potential.
- Monitor: Exchange rate development (CHF strength threatens price competitiveness).
For Importers & Suppliers:
- Check supply chain stability; rising demand requires capacity planning.
- Monitor: Raw material availability and transport costs.
For Political Decision-Makers:
- Review: Export economy dependence on chemical-pharma; promote diversification.
- Monitor: Trade policy risks (sanctions, tariffs).
Quality Assurance & Fact-Checking
- [x] Central statements and figures verified
- [x] Unconfirmed data marked with ⚠️
- [ ] Web research for current data conducted (not required – official statistics)
- [ ] Bias or political one-sidedness marked
Note: All figures come directly from the press release of the Swiss foreign trade statistics office. No contradictions or ambiguities identified.
Supplementary Research
⚠️ No additional sources provided in metadata. For in-depth analysis recommended:
- Detailed sector figures (chemical vs. pharmaceutical share of export growth)
- Geographic distribution of exports (top markets)
- Comparison with OECD countries and EU trading partners
Source Directory
Primary Source:
Press Release from the State Secretariat for Economic Affairs (SECO) – news.admin.ch – January 29, 2026
Verification Status: ✓ Facts checked on 29.01.2026
Footer (Transparency Notice)
This text was created with the support of Claude.
Editorial Responsibility: clarus.news | Fact-Check: 29.01.2026